Terms: = Prostate cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
222 results:
1. Primary mucinous adenocarcinoma of the urethra: A contemporary clinicopathologic analysis of 17 patients.
Alrohaibani A; Osunkoya AO
Pathol Res Pract; 2024 Apr; 256():155273. PubMed ID: 38565023
[TBL] [Abstract] [Full Text] [Related]
2. Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.
Bührer E; D'Haese D; Daugaard G; de Wit R; Albany C; Tryakin A; Fizazi K; Stahl O; Gietema JA; De Giorgi U; Cafferty FH; Hansen AR; Tandstad T; Huddart RA; Necchi A; Sweeney CJ; Garcia-Del-Muro X; Heng DYC; Lorch A; Chovanec M; Winquist E; Grimison P; Feldman DR; Terbuch A; Hentrich M; Bokemeyer C; Negaard H; Fankhauser C; Shamash J; Vaughn DJ; Sternberg CN; Heidenreich A; Collette L; Gillessen S; Beyer J
Eur J Cancer; 2024 May; 202():114042. PubMed ID: 38564927
[TBL] [Abstract] [Full Text] [Related]
3. [Functional outcomes of robot-assisted radical prostatectomy with preservation of pelvic stabilized structure and early elevated retrograde liberation of neurovascular bundle].
Liao XY; Bao YG; Liu ZH; Yang L; Qiu S; Liu LR; Han P; Wei Q
Zhonghua Wai Ke Za Zhi; 2024 Feb; 62(2):128-134. PubMed ID: 38310380
[No Abstract] [Full Text] [Related]
4. Adrenal incidentalomas, cortisol secretion and cancer: is there a real crosstalk?
Herrera-Martínez AD; Román ÁR; Corrales EP; Idrobo C; Ramírez PP; Rojas PM; Lázaro CR; Araujo-Castro M
Front Endocrinol (Lausanne); 2023; 14():1335202. PubMed ID: 38264281
[TBL] [Abstract] [Full Text] [Related]
5. Dosiomics for intensity-modulated radiotherapy in patients with prostate cancer: survival analysis stratified by baseline prostate-specific antigen and Gleason grade group in a 2-institutional retrospective study.
Murakami Y; Kawahara D; Soyano T; Kozuka T; Takahashi Y; Miyake K; Kashihara K; Kashihara T; Kamima T; Oguchi M; Murakami Y; Yoshioka Y; Nagata Y
Br J Radiol; 2024 Jan; 97(1153):142-149. PubMed ID: 38263831
[TBL] [Abstract] [Full Text] [Related]
6. Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice.
Maekawa S; Takata R; Sekiguchi K; Kagabu M; Toyoshima M; Tamada S; Takahashi K; Ikarashi D; Matsuura T; Kato R; Kato Y; Kanehira M; Sugimura J; Abe T; Baba T; Obara W
Jpn J Clin Oncol; 2024 Apr; 54(4):489-497. PubMed ID: 38157885
[TBL] [Abstract] [Full Text] [Related]
7. C reactive protein/Albumin ratio as predictor of prognosis in castration resistant metastatic prostate cancer.
Lorigo J; Tavares Silva E; Pedroso Lima J; Quaresma V; Pedrosa R; Figueiredo A
Arch Ital Urol Androl; 2023 Jul; 95(3):11242. PubMed ID: 37435750
[TBL] [Abstract] [Full Text] [Related]
8. Long-Term prognosis and Treatment Strategy of Persistent PSA After Radical prostatectomy.
Komori T; Matsumoto K; Kosaka T; Takeda T; Kamitani R; Yasumizu Y; Tanaka N; Morita S; Mizuno R; Asanuma H; Oya M
Ann Surg Oncol; 2023 Oct; 30(11):6936-6942. PubMed ID: 37418130
[TBL] [Abstract] [Full Text] [Related]
9. High monoamine oxidase a expression predicts poor prognosis for prostate cancer patients.
Chen L; Xiong W; Qi L; He W
BMC Urol; 2023 Jul; 23(1):112. PubMed ID: 37403079
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular cancer: Utility of the Australian and New Zealand Urogenital and prostate cancer Trials Group Surveillance Recommendations.
Conduit C; Lewin J; Weickhardt A; Lynam J; Wong S; Grimison P; Sengupta S; Pranavan G; Parnis F; Bastick P; Campbell D; Hansen AR; Leonard M; McJannett M; Stockler MR; Gibbs P; Toner G; Davis ID; Tran B; Kuchel A
JCO Oncol Pract; 2023 Nov; 19(11):973-980. PubMed ID: 37327464
[TBL] [Abstract] [Full Text] [Related]
11. Diabetes and prostate cancer Outcomes in Men with Nonmetastatic Castration-Resistant prostate cancer: Results from the SEARCH Cohort.
Sergeyev A; Gu L; De Hoedt AM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Klaassen Z; Terris MK; Guerrios-Rivera L; Freedland SJ; Csizmadi I
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1208-1216. PubMed ID: 37294698
[TBL] [Abstract] [Full Text] [Related]
12. Conditional survival does not improve over time in metastatic castration-resistant prostate cancer patients undergoing docetaxel.
Modonutti D; Majdalany SE; Butaney M; Davis MJ; Corsi N; Sood A; Trinh QD; Cole AP; Rogers CG; Novara G; Abdollah F
Prostate; 2023 Sep; 83(13):1238-1246. PubMed ID: 37290911
[TBL] [Abstract] [Full Text] [Related]
13. Aspartoacylase suppresses prostate cancer progression by blocking LYN activation.
Weng H; Xiong KP; Wang W; Qian KY; Yuan S; Wang G; Yu F; Luo J; Lu MX; Yang ZH; Liu T; Huang X; Zheng H; Wang XH
Mil Med Res; 2023 Jun; 10(1):25. PubMed ID: 37271807
[TBL] [Abstract] [Full Text] [Related]
14. Head-to-Head Comparison of
Exterkate L; Hermsen R; Küsters-Vandevelde HVN; Prette JF; Baas DJH; Somford DM; van Basten JA
Eur Urol Oncol; 2023 Dec; 6(6):574-581. PubMed ID: 37230883
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.
Sutera PA; Shetty AC; Hakansson A; Van der Eecken K; Song Y; Liu Y; Chang J; Fonteyne V; Mendes AA; Lumen N; Delrue L; Verbeke S; De Man K; Rana Z; Hodges T; Hamid A; Roberts N; Song DY; Pienta K; Ross AE; Feng F; Joniau S; Spratt D; Gillessen S; Attard G; James ND; Lotan T; Davicioni E; Sweeney C; Tran PT; Deek MP; Ost P
Ann Oncol; 2023 Jul; 34(7):605-614. PubMed ID: 37164128
[TBL] [Abstract] [Full Text] [Related]
16. P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer.
Röbeck P; Xu L; Ahmed D; Dragomir A; Dahlman P; Häggman M; Ladjevardi S
Prostate; 2023 Jun; 83(9):831-839. PubMed ID: 36938873
[TBL] [Abstract] [Full Text] [Related]
17. Association between Alcohol Intake and prostate cancer Mortality and Survival.
D'Ecclesiis O; Pastore E; Gandini S; Caini S; Marvaso G; Jereczek-Fossa BA; Corrao G; Raimondi S; Bellerba F; Ciceri S; Latella M; Cavalcabò NB; Bendinelli B; Saieva C; Fontana M; Gnagnarella P
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839283
[TBL] [Abstract] [Full Text] [Related]
18. ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical prostatectomy With Positive Surgical Margins.
Salles DC; Mendes AA; Han M; Partin AW; Trock BJ; Jing Y; Lotan TL
Mod Pathol; 2023 Jul; 36(7):100147. PubMed ID: 36828362
[TBL] [Abstract] [Full Text] [Related]
19. Seasonal effects on cancer incidence and prognosis.
Wikén I; Andersson TM; Radkiewicz C
Acta Oncol; 2023 Feb; 62(2):103-109. PubMed ID: 36790070
[TBL] [Abstract] [Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio predicts nodal involvement in unfavourable, clinically nonmetastatic prostate cancer patients and overall survival in pN1 patients.
Zapała P; Garbas K; Lewandowski Z; Ślusarczyk A; Ślusarczyk C; Mielczarek Ł; Marra G; Pradere B; Rajwa P; Zapała Ł; Radziszewski P
Sci Rep; 2023 Jan; 13(1):392. PubMed ID: 36624246
[TBL] [Abstract] [Full Text] [Related]
[Next]
